C26-Ceramide as highly sensitive biomarker for the diagnosis of Farber Disease
Abstract Farber disease (FD) is a rare autosomal recessive disease caused by mutations in the acid ceramidase gene (ASAH1). Low ceramidase activity results in the accumulation of fatty substances, mainly ceramides. Hallmark symptoms at clinical level are periarticular nodules, lipogranulomas, swolle...
Guardado en:
Autores principales: | Claudia Cozma, Marius-Ionuț Iurașcu, Sabrina Eichler, Marina Hovakimyan, Oliver Brandau, Susanne Zielke, Tobias Böttcher, Anne-Katrin Giese, Jan Lukas, Arndt Rolfs |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a267cbff6a5140b1bcde5f0b575397b9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Revolutionary Intertextuality of Molora by Yäel Farber
por: Zinato, Susanna
Publicado: (2021) -
Ceramides: Shared Lipid Biomarkers of Cardiovascular Disease and Schizophrenia
por: Anna I. Tkachev, et al.
Publicado: (2021) -
Ceramide Remodeling and Risk of Cardiovascular Events and Mortality
por: Linda R. Peterson, et al.
Publicado: (2018) -
Plasma Ceramides Pathophysiology, Measurements, Challenges, and Opportunities
por: Melania Gaggini, et al.
Publicado: (2021) -
Ceramide structure dictates glycosphingolipid nanodomain assembly and function
por: Senthil Arumugam, et al.
Publicado: (2021)